Drug General Information
Drug ID	D07ZBH
Former ID	DNC006147
Drug Name	4-hydroxybenzylamine
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[527869]
Structure		Download 2D MOL 3D MOL
Formula	C7H9NO
Canonical SMILES	C1=CC(=CC=C1CN)O
InChI	1S/C7H9NO/c8-5-6-1-3-7(9)4-2-6/h1-4,9H,5,8H2
InChIKey	RQJDUEKERVZLLU-UHFFFAOYSA-N
PubChem Compound ID	97472
Target and Pathway
Target(s)	4-aminobutyrate aminotransferase, mitochondrial	Target Info	Inhibitor	[527869]
BioCyc Pathway	GABA shunt
	Valine degradation
	Beta-alanine degradation
	4-aminobutyrate degradation
KEGG Pathway	Alanine, aspartate and glutamate metabolism
	Valine, leucine and isoleucine degradation
	beta-Alanine metabolism
	Propanoate metabolism
	Butanoate metabolism
	Metabolic pathways
	GABAergic synapse
PANTHER Pathway	Aminobutyrate degradation
	Pyrimidine Metabolism
	Gamma-aminobutyric acid synthesis
PathWhiz Pathway	Aspartate Metabolism
	Glutamate Metabolism
	Beta-Alanine Metabolism
	Valine, Leucine and Isoleucine Degradation
	Propanoate Metabolism
WikiPathways	GABA synthesis, release, reuptake and degradation
	Alanine and aspartate metabolism
References
Ref 527869	Bioorg Med Chem Lett. 2006 Feb;16(3):592-5. Epub 2005 Nov 14.Inhibition of GABA shunt enzymes' activity by 4-hydroxybenzaldehyde derivatives.
Ref 527869	Bioorg Med Chem Lett. 2006 Feb;16(3):592-5. Epub 2005 Nov 14.Inhibition of GABA shunt enzymes' activity by 4-hydroxybenzaldehyde derivatives.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.